STRO
Sutro Biopharma Inc

1,094
Loading...
Loading...
News
all
press releases
Sutro Biopharma, Inc. (STRO) Reports Q2 Loss, Beats Revenue Estimates
Sutro Biopharma (STRO) delivered earnings and revenue surprises of +64.10% and +293.54%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
More News
News Placeholder
Cytokinetics (CYTK) Reports Q2 Loss, Tops Revenue Estimates
Cytokinetics (CYTK) delivered earnings and revenue surprises of +16.42% and +1,658.00%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Teladoc (TDOC) Moves 14.4% Higher: Will This Strength Last?
Teladoc (TDOC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Zacks·3mo ago
News Placeholder
Strength Seen in CorMedix (CRMD): Can Its 21.7% Jump Turn into More Strength?
CorMedix (CRMD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks·3mo ago
News Placeholder
EyePoint Pharmaceuticals (EYPT) Reports Q1 Loss, Tops Revenue Estimates
chainwire·5mo ago
News Placeholder
Peeling Back The Layers: Exploring Sutro Biopharma Through Analyst Insights
Latest Ratings for STRO DateFirmActionFromTo Nov 2021BerenbergInitiates Coverage OnBuy Jun 2021HC Wainwright & Co.Initiates Coverage OnBuy Dec 2020StifelInitiates Coverage OnBuy View More...
Benzinga·1y ago
News Placeholder
Cancer Research Sees Major Boost as New Breakthroughs Emerge from Key Oncology Players
Cancer Research Sees Major Boost as New Breakthroughs Emerge from Key Oncology Players Cancer Research Sees Major Boost as New Breakthroughs Emerge from Key Oncology Players PR Newswire VANCOUVER...
PR Newswire·1y ago
News Placeholder
Truist Financial Sticks to Their Buy Rating for Sutro Biopharma (STRO)
In a report released today, Asthika Goonewardene from Truist Financial maintained a Buy rating on Sutro Biopharma (STRO Research Report), with a...
TipRanks Financial Blog·1y ago
News Placeholder
Sutro Biopharma's Strong Financials and Clinical Progress Reinforce Buy Rating
In a report released today, Reni Benjamin from JMP Securities reiterated a Buy rating on Sutro Biopharma (STRO Research Report), with a price tar...
TipRanks Financial Blog·1y ago
News Placeholder
Q1 2024 EPS Estimates for Sutro Biopharma, Inc. (NASDAQ:STRO) Boosted by Wedbush
Sutro Biopharma, Inc. (NASDAQ:STRO - Free Report) - Research analysts at Wedbush lifted their Q1 2024 earnings per share estimates for shares of Sutro Biopharma in a report issued on Tuesday...
Zolmax·1y ago

Latest STRO News

View

Advertisement|Remove ads.

Advertisement|Remove ads.